Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease-Reference-Cited by-同舟云学术

Frequency and correlates of treatment intensification for elevated cholesterol levels in patients with cardiovascular disease

Published:2011-10 Issue:4 Volume:162 Page:725-732.e1
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Virani Salim S.,Woodard LeChauncy D.,Chitwood Supicha S.,Landrum Cassie R.,Urech Tracy H.,Wang Degang,Murawsky Jeffrey,Ballantyne Christie M.,Petersen Laura A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

2. Avoiding pitfalls in chronic disease quality measurement: a case for the next generation of technical quality measures;Kerr;Am J Manag Care,2001

3. Building a better quality measure: are some patients with ‘poor quality’ actually getting good care?;Kerr;Med Care,2003

4. Treatment intensification and risk factor control: toward more clinically relevant quality measures;Selby;Med Care,2009

5. Clinical inertia;Phillips;Ann Intern Med,2001

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications;American Journal of Cardiovascular Drugs;2024-08-13

2. Discovery of Oral AMP-Activated Protein Kinase Activators for Treating Hyperlipidemia;Journal of Medicinal Chemistry;2024-05-13

3. An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease;Journal of the American College of Cardiology;2024-05

4. The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive Cardiology;Journal of Clinical Lipidology;2023-03

5. The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint clinical perspective from the National Lipid Association and the American Society for Preventive Cardiology;American Journal of Preventive Cardiology;2023-03